[Does epilepsy surgery really lower mortality?].
Patients with epilepsy suffer from a two to three fold increased death rate as compared to age and sex matched control population. This increased risk culminate to five fold in patients with drug resistant partial epilepsy eligible for epilepsy surgery, with the majority of deaths classified as sudden unexpected death in epilepsy (SUDEP). The pathophysiology of SUDEP remains uncertain, but all witnessed cases occurred during or immediately after a seizure. Several studies have evaluated the impact of epilepsy surgery on the risk of seizure related death and SUDEP. Four series have concentrated on operated patients, and have compared the death rates in those seizure free and non seizure free post-operatively. Three of these studies reported a significantly lower risk of SUDEP in patients cured by surgery as compared to those still seizing. Four other series have compared the mortality in surgically versus medically treated patients with refractory partial epilepsy. Three of these studies failed to show any significant difference in death or SUDEP rates between operated and and non operated patients. All the above series suffer various types of methological limitations, hampering any definite conclusion regarding the impact of epilepsy surgery on mortality. The launching of novel and large multicentric studies, which address the pitfalls of prior series, should allow to provide conclusive results within the next three years.
Ryvlin
P
P
Service de neurologie fonctionnelle et d'épileptologie, CTRS-Inserm-institut des épilepsies de l'enfant et de l'adolescent (IDEE), hospices civils de Lyon, Inserm U821, Lyon, France. ryvlin@cermep.fr
Montavont
A
A
D000927:Anticonvulsants / Q000627:therapeutic use; D004351:Drug Resistance; D004827:Epilepsy / Q000188:drug therapy / Q000401:mortality* / Q000601:surgery*; D006801:Humans; D019635:Neurosurgical Procedures; D013702:Temporal Lobe / Q000473:pathology / Q000601:surgery; D016896:Treatment Outcome
D000927:Anticonvulsants